Regeneron likely to test treatments in coronavirus patients in few months

Regeneron Pharmaceuticals Inc said on Thursday a set of its treatments could be available for testing in coronavirus patients within a few months.

"We're already scaling up one set of potential antibody treatments," Chief Scientific Officer George Yancopoulos said on a conference call with analysts.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)